This collaborative article reviews chronic pulmonary aspergillosis (CPA) from the perspective of a multidisciplinary team comprising of respiratory physicians, radiologists, mycologists, dietitians, pharmacists, physiotherapists and palliative care specialists. The review synthesises current knowledge on CPA, emphasising the intricate interplay between clinical, radiological, and microbiological aspects. We highlight the importance of assessing each patient as a multidisciplinary team to ensure personalised treatment strategies and a holistic approach to patient care.
Share this post
Latest News posts
⭐ Recent Aspergillosis Research Updates (Week 48)
November 26, 2025
🌿 Biologics when ABPA and CPA overlap: What Patients Need to Know
November 25, 2025
🌍 Does where you live affect aspergillosis or ABPA?
November 25, 2025
🎄 Why Christmas Decorations Can Trigger Symptoms
November 25, 2025
Side effects from Biologic Medication
November 24, 2025
Could this new gene-therapy technology help aspergillosis patients?
November 24, 2025
**Adrenal Insufficiency & Steroid Tapering:
November 20, 2025
**Understanding Medicines in Rare Forms of Aspergillosis:
November 20, 2025
News archive
× Close
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Research
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel & Insurance
- Treatment
- Vaccines
- Weekly Updates
